MS Franchise A Surprising Concern For Sanofi In Q3; Dupixent Out-Performs

 
• By Lucie Ellis-Taitt
  
Pressure
Sanofi MS franchise under pressue after disappointing growth in Q3 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business